J
James A. Feinstein
Researcher at University of Colorado Boulder
Publications - 65
Citations - 2625
James A. Feinstein is an academic researcher from University of Colorado Boulder. The author has contributed to research in topics: Medicine & Polypharmacy. The author has an hindex of 18, co-authored 53 publications receiving 1811 citations. Previous affiliations of James A. Feinstein include Anschutz Medical Campus & Children's Hospital of Philadelphia.
Papers
More filters
Journal ArticleDOI
Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation
Chris Feudtner,Chris Feudtner,James A. Feinstein,James A. Feinstein,Wenjun Zhong,Matthew Hall,Dingwei Dai +6 more
TL;DR: The updated CCC v2 system consists of diagnostic and procedural codes that incorporate a new neonatal CCC category as well as domains of complexity arising from technology dependence or organ transplantation and provides a necessary update to accommodate widespread implementation of ICD-10.
Journal ArticleDOI
Shifting place of death among children with complex chronic conditions in the United States, 1989-2003.
TL;DR: Children who die with underlying complex chronic conditions increasingly are dying at home and racial and ethnic disparities regarding place of death may represent important limitations and opportunities for improvement in the current systems of pediatric chronic and palliative care.
Journal ArticleDOI
Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review.
Pamela F. Weiss,James A. Feinstein,Xianqun Luan,Jon M. Burnham,Chris Feudtner,Chris Feudtner +5 more
TL;DR: A meta-analysis based on a comprehensive review of the literature in the Medline database and the Cochrane Controlled Trials Register found corticosteroid treatment given early in the course of illness seem to produce consistent benefits for several major clinically relevant Henoch-Schönlein purpura outcomes.
Journal ArticleDOI
Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review.
TL;DR: Clinicians must rely on the limited available data, as well as clinical expertise, when managing sleep disorders in the population of children with NDDs, and parents and caregivers should be provided with appropriate education on the nature of the sleep disorders.
Journal ArticleDOI
Potential Drug−Drug Interactions in Infant, Child, and Adolescent Patients in Children’s Hospitals
TL;DR: Exposure to PDDIs is common among hospitalized children, and Empirical data are needed to determine the probability and magnitude of the actual harm for each specific PDDI, particularly for less common drug pairs.